TRANSFORMING GROWTH-FACTOR-BETA - THE ELUSIVE HEPATIC CHALONE

被引:4
|
作者
STRAIN, AJ
机构
[1] Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, Edgbaston
关键词
D O I
10.1002/hep.1840160139
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Incubation of fetal rat hepatocytes (FRH) with transforming growth factor β1 (TGF‐β1) resulted in growth arrest and a biphasic effect on epidermal growth factor (EGF) receptor. After 2 h of exposure, EGF receptor (EGFR) was reduced by 43%. From 6 to 24 h, TGF‐β1 exposure resulted in progressive increase in EGFR up to 74% over control. The increased binding was due to increase in high affinity EGF binding sites. FRH grown in medium containing EGF exhibited down‐regulated EGFR with loss of high affinity EGF binding sites. With TGF‐β1 exposure, high affinity EGFR was not down‐regulated by EGF. Since downregulation of EGFR involves internalization, the kinetics of EGF receptor‐mediated endocytosis were examined. In TGF‐β1 exposed FRH, EGF endocytosis was inhibited, with a reduction in the first order rate constant for the process from 0.078 to 0.043 min−1. Despite inhibition of growth, receptor downregulation, and EGF endocytosis after TGF‐β1 exposure, EGF‐induced receptor autophosphorylation was preserved as demonstrated by [32P]phosphatelabeling of immunoprecipitated EGFR. These observations provide direct evidence that TGF‐β1 regulates growth of fetal cells. Further, they suggest that TGF‐β1 regulates endocytosis of EGF and possibly of other ligands. Copyright © 1992 American Association for the Study of Liver Diseases
引用
收藏
页码:269 / 270
页数:2
相关论文
共 50 条
  • [21] TRANSFORMING GROWTH-FACTOR-BETA INHIBIN FAMILY
    ROBERTSON, DM
    BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1991, 5 (04): : 615 - 634
  • [22] MEDIATION OF CARDIOPROTECTION BY TRANSFORMING GROWTH-FACTOR-BETA
    LEFER, AM
    TSAO, P
    AOKI, N
    PALLADINO, MA
    SCIENCE, 1990, 249 (4964) : 61 - 64
  • [23] TRANSFORMING GROWTH-FACTOR-BETA - IS IT AN ENDOGENOUS CARDIOPROTECTOR
    DAS, UN
    MEDICAL SCIENCE RESEARCH, 1993, 21 (10): : 373 - 375
  • [24] THE IMMUNOREGULATORY ROLES OF TRANSFORMING GROWTH-FACTOR-BETA
    SOSROSENO, W
    HERMINAJENG, E
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 1995, 52 (02) : 142 - 148
  • [25] PLASMA TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) LEVELS IN HEPATIC-FIBROSIS
    TROTTER, J
    WASHINGTON, K
    KONG, FM
    JIRTLE, R
    HEPATOLOGY, 1995, 22 (04) : 721 - 721
  • [26] TRANSFORMING GROWTH-FACTOR-BETA IN TISSUE FIBROSIS
    BORDER, WA
    NOBLE, NA
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19): : 1286 - 1292
  • [27] THE MECHANISM OF ACTION OF TRANSFORMING GROWTH-FACTOR-BETA
    MIYAZONO, K
    HELDIN, CH
    GASTROENTEROLOGIA JAPONICA, 1993, 28 : 81 - 85
  • [28] TRANSFORMING GROWTH-FACTOR-BETA AND REMODELING OF BONE
    CENTRELLA, M
    MCCARTHY, TL
    CANALIS, E
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1991, 73A (09): : 1418 - 1428
  • [29] CARDIOPROTECTIVE ACTIONS OF TRANSFORMING GROWTH-FACTOR-BETA
    ROBERTS, AB
    SPORN, MB
    LEFER, AM
    TRENDS IN CARDIOVASCULAR MEDICINE, 1993, 3 (03) : 77 - 81
  • [30] SIGNALING BY THE TRANSFORMING GROWTH-FACTOR-BETA RECEPTORS
    YINGLING, JM
    WANG, XF
    BASSING, CH
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1995, 1242 (02): : 115 - 136